BLAINE PHARMACEUTICALS HIRES MARK RINKER AS DIRECTOR OF INTERNATIONAL SALES 

CINCINNATI, O.H., November 6, 2006-Blaine Pharmaceuticals has added Mark Rinker to its team as director of international sales. In this position, Rinker will concentrate on gaining over-the-counter (OTC) distribution with major retailers in Canada to promote Blaine's products, including DiaSense nutritional supplements and Mag-Ox 400, the number one doctor-recommended magnesium supplement on the market. He will also work to expand Blaine's distribution to the United Kingdom and other countries in Europe, Asia, and South America. In addition, Rinker will be instrumental in evaluating and adding innovative OTC products to complement the existing Blaine product portfolio.

Previously, Rinker worked as director of Canadian operations for Omron Healthcare, the worldwide leader of blood pressure monitors, thermometry, weight management, and respiratory products. At Omron, Rinker successfully established Canadian operations and was part of an outstanding sales force capable of responding to rapid growth, expansion of existing product categories, and new product initiatives. Prior to Omron, Rinker worked as a national sales manager with Magna-Pak, Inc., and as a business development manager at Becton Dickinson Canada.

About Blaine PharmaceuticalsBlaine Pharmaceuticals, based in the Greater Cincinnati area, has been trusted for more than 50 years to deliver quality products for better health, including MagOx 400, the number one doctor-recommended magnesium supplement. Blaine is focused on cultivating relationships with physicians, pharmacists, patients, wholesalers, retailers, and other business partners to promote current products and lay the foundation for future endeavors. For more information, visit www.blainepharma.com.